未登录

H

Han Qu

medicine

H指数:7

被引数:145

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gastrointestinal and skin safety evaluation of pirfenidone versus nintedanib: an analysis of real-world pharmacovigilance and randomized controlled trials

吡非尼酮与尼达尼布的胃肠道和皮肤安全性评估：真实世界药物警戒和随机对照试验分析

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2026-09-190

PRE

Sex and age disparities in goserelin safety: a global pharmacovigilance study

戈舍瑞林安全性中的性别与年龄差异：一项全球药物警戒研究

Naunyn-Schmiedeberg's Archives of Pharmacology

IF3.1

2026-03-090

PRE

Efficient near-telomere-to-telomere assembly of nanopore simplex reads

纳米孔单形读数的高效近端粒到端粒组装

IF48.5

2026-02-040

OA

A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase

一项关于Bruton’s tyrosine kinase inhibitors的药物警戒研究：一项基于FAERS和VigiBase的多维分析

Frontiers in Immunology

IF5.9

2025-11-260

OAAI

Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS

IF8.3

2024-08-130

OAAI

Antidepressant-like effects of hyperoside on chronic stress-induced depressive-like behaviors in mice: Gut microbiota and short-chain fatty acids

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2024-06-015

PRE

Recycling preparative isolation of six bicyclol active metabolites from SD rat urine using macroporous resin, offline 2D LPLC/HPLC, and prep-HPLC combined with pharmacodynamic evaluation of two active metabolites

ARABIAN JOURNAL OF CHEMISTRY

IF5.2

2023-10-012

OAAI

Safety Profile of Eltrombopag in Different Age Groups: An Analysis of Real-World Pharmacovigilance and Randomized Clinical Trials

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-05-082

PRE

Exploring the components and mechanisms of Shen-qi-wang-mo granule in the treatment of retinal vein occlusion by UPLC-Triple TOF MS/MS and network pharmacology

SCIENTIFIC REPORTS

IF3.9

2023-04-013

OAAI

A systematic comparison of anti-angiogenesis efficacy and cardiotoxicity of receptor tyrosine kinase inhibitors in zebrafish model

受体酪氨酸激酶抑制剂在斑马鱼模型中的抗血管生成功效和心脏毒性的系统比较

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2022-09-015

PRE